Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase 1 11Phase 3 6Phase NA 4Phase 4 2Phase 2/3 2Phase 1/2 1

Status

Unknown 12Recruiting 4Completed 4Not yet recruiting 2Withdrawn 1Terminated 1Suspended 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 1

Conditions

Drug-Related Side Effects and Adverse Reactions 2Stomach Neoplasms 1Quality of Life 1Osteosarcoma 1Chondrosarcoma 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Completed × apatinib × Clear all
NCT04690231 2022-03-15

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Peking University People's Hospital

Phase NA Completed
79 enrolled
Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT02764268 2022-03-11

Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase NA Completed
60 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04260113 2021-01-05

AIAC

Peking University People's Hospital

Phase NA Completed
40 enrolled
Sarcoma

Chondrosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT02998242 2019-05-21

ARCAP

Sichuan Provincial People's Hospital

Phase NA Completed
40 enrolled

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon âš¡